VANCOUVER, BRITISH COLUMBIA--(Marketwire - February 05, 2009) - Meridian Co., Ltd., (OTCBB: MRDAF) a company engaged in the research, development, manufacturing, and sales of advanced medical devices, is pleased to announce that it has been deemed a reporting issuer in British Columbia.
Meridian is now filing regulatory period reports on Canada's System for Electronic Document Analysis and Retrieval (SEDAR) so that investors and shareholders all across Canada can download and view current regulatory reports filed by the Company. Canadian investors and shareholders now will enjoy the same access to Meridian's filings as our shareholders in the United States. Sedar filings can be viewed at http://www.sedar.com/homepage_en.htm.
Meridian is a leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 5 patents on its technology, and has received FDA approval, Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe. Meridian continues to successfully market its superior product line to a growing number of clients worldwide.
Safe Harbor Statement
This press release contains certain forward-looking information and statements concerning the company's future operations, performance and financial condition. These statements include that Meridian continues to successfully market its superior product line to a growing number of clients worldwide. Forward looking statements are subject to a number of risks, uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Risk factors which could prevent the foregoing statements from being accurate include possible lesser market acceptance of our medical devices than anticipated. The Company does not update its forward looking information. This document is not intended to be and is not an advertisement for any securities of the Company.